Results: Clinical case 2 describes a 48-year-old woman with a history of Takayasus arteritis, prior proximal descending thoracic aorta to infrarenal abdominal aortic bypass and bypass to the left renal artery for mid-aortic syndrome, and atrophic right kidney presented with severe hypertension, fluid overload, and hyperkalemia, and a creatinine of 5.8 mg/dL requiring urgent dialysis. She was anuric and dialysis dependent. Magnetic resonance angiography revealed occlusion of the left renal artery bypass which originated from the aortic bypass graft and collateral filling of the left kidney with differential areas of perfusion (Fig 2) . She underwent redo aortic graft to left renal artery bypass 18 days after her initial presentation. Upon discharge, she was no longer dialysis dependent and her creatinine has normalized.
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Derivation and Validation of Thoracic Sarcopenia Assessment in Patients Undergoing Thoracic Endovascular Aortic Repair
Objectives: Sarcopenia, as assessed by computed tomographic (CT) based measurements of muscle mass, is an objective and patient-specific indicator of frailty, which is an important predictor of operative morbidity and mortality. However, studies to date have primarily focused on psoasdefined sarcopenia, which may not be available or valid among patients with thoracic aortic disease. Using psoas sarcopenia as the reference for sarcopenia, the purpose of this study was to validate thoracic level measurements of sarcopenia as a novel method to assess frailty among patients undergoing thoracic endovascular aortic repair (TEVAR).
Methods: This was a post hoc analysis prospective data of patients undergoing TEVAR for thoracic aortic dissection, aneurysm, or injury using the conformable GORE TAG device (W. L. Gore & Associates, Inc., Newark, Del). Patients with core-lab preoperative abdominal and thoracic CT imaging were included. Thoracic muscle mass was measured at the T12 level (rectus abdominis, latissimus dorsi, intercostal, erector spinae, and external and internal obliques) using an automated sequence. Psoas sarcopenia was measured at the L3 level using standard methods. All measurements were expressed as muscle cm 2 /height m 2 . A subset of scans were reviewed in duplicate by two trained observers, intraoperative and interobserver reliability tested by intraclass correlation coefficient (scale 0-1). Sex specific cutoffs for thoracic sarcopenia were determined by receiver operator characteristic (ROC) plots, and agreement between T12 and L3 sarcopenia tested by Cohens kappa (scale 0-1).
Results: One hundred fifty patients were included for analysis, including 44 dissection, 45 injury, and 61 aneurysm patients. Intraobserver and inter-observer reliabilities for T12 muscle mass measurements were >0.95, indicating very high precision. T12 measurements had strong correlation with L3 values (Fig 1) . Based on receiver operating characteristic (ROC) analysis, overall accuracy of T12 measurements was high (area under ROC 0.92 for males, 0.83 for females), and T12 sarcopenia was defined as <18 for females and <27.5 for males (Fig 2) . Based on the defined T12 sarcopenia threshold, agreement with L3 sarcopenia was substantial (accuracy 83%; 95% CI, 0.76 0.88; kappa 0.58).
Conclusions: Thoracic sarcopenia can be readily and reproducibly assessed from CT-derived measurement of T12 level muscle mass. This approach may be used as an alternative method to objectively define sarcopenia in patients without abdominal CT imaging. Although this novel method accurately defines sarcopenia among patients undergoing TEVAR, further research is required to determine if either method is a superior predictor of clinical outcomes among patients with thoracic aortic disease.
